On Nov. 1, 2018, a research grant for $25,000 has been awarded to the research project: Aptameric Targeting of CD19 B-lymphocyte Transmembrane Receptor via Molecular Simulations for Acute Lymphoblastic Leukemia Therapy. The grant was awarded through the inaugural competition of the Collaborative Research Grant initiative, a partnership between UTC, the University of Tennessee College of Medicine Chattanooga and the Erlanger Health System. The research team is led by UTC’s…